Table 1 Laboratory data at admission of our patient

 RBC

309

× 10⁴/μL

(435–555)

 Ht

26.1

%

(40.7–50.1)

 Hb

8.3

g/dL

(13.7–16.8)

 Plt

25.4

× 10⁴/μL

(15.8–34.8)

 WBC

27.4

× 10³/μL

(3.3–8.6)

 neu

49

%

(41.2–74.7)

 lym

2

%

(21.2–51.0)

 mon

1

%

(3.1–8.0)

 eos

48

%

(0.2–4.8)

 bas

0

%

(0.1–1.0)

 IgG

2540

mg/dL

(870–1700)

 IgA

147

mg/dL

(110–410)

 IgM

106

mg/dL

(35–220)

 IgE

1913

IU/mL

(< 100.0)

 CRP

4.73

mg/dL

(< 0.14)

 ANA

< 40

×

(< 40)

 MPO-ANCA

(−)

(−)

 PR3-ANCA

(−)

(−)

 GBM Ab

(−)

(−)

 sIL2R

4834

U/mL

(127–582)

 TP

7.3

g/dL

(6.6–8.1)

 FBS

89

mg/dL

(73–109)

 Alp

350

U/L

(106–322)

 t-Cho

122

mg/dL

(142–322)

 γ-GTP

18

U/L

(13–64)

 t-Bil

0.3

mg/dL

(0.4–1.5)

 d-Bil

0.1

mg/dL

(< 0.4)

 ChE

147

U/L

(240–486)

 Glb

5.1

g/dL

(2.2–3.4)

 Alb

2.2

g/dL

(4.1–5.1)

 ALT

13

U/L

(10–42)

 AST

17

U/L

(13–30)

 LDH

324

U/L

(124–222)

 CPK

159

U/L

(59–248)

 SCr

5.6

mg/dL

(0.65–1.07)

 BUN

43

mg/dL

(8–20)

 UA

5.6

mg/dL

(3.7–7.8)

 Amy

51

U/L

(44–132)

 HbA1c

5.8

%

(4.6–6.2)

 HCV Ab

(+)

(−)

 HBs Ag

(−)

(−)